The Alzheimer’s Association has said it hopes the Centers for Medicare and Medicaid Services “will move quickly” to cover lecanemab for Alzheimer’s patients. “It will take clinicians some time to be available to parse out how this drug may or may not be effective in their own individual patients,” an expert said. The Alzheimer’s Association…